Publication
Two Years Later, Azithromycin for COVID-19 and the Effect on the Heart, Is it Still Relevant?
| dc.contributor.author | Laranjo, S | |
| dc.date.accessioned | 2023-05-16T14:45:33Z | |
| dc.date.available | 2023-05-16T14:45:33Z | |
| dc.date.issued | 2022 | |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Rev Port Cardiol. 2022 Jul;41(7):557-558 | pt_PT |
| dc.identifier.doi | 10.1016/j.repc.2022.04.005 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.17/4515 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Elsevier | pt_PT |
| dc.subject | Azithromycin | pt_PT |
| dc.subject | COVID-19 | pt_PT |
| dc.subject | Heart | pt_PT |
| dc.subject | HSM CAR PED | pt_PT |
| dc.title | Two Years Later, Azithromycin for COVID-19 and the Effect on the Heart, Is it Still Relevant? | pt_PT |
| dc.title.alternative | Dois Anos Mais Tarde, Azitromicina para Covid-19 e os seus Efeitos Cardíacos, Ainda É Relevante? | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 558 | pt_PT |
| oaire.citation.issue | 7 | pt_PT |
| oaire.citation.startPage | 557 | pt_PT |
| oaire.citation.title | Revista Portuguesa de Cardiologia | pt_PT |
| oaire.citation.volume | 41 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |